Skip to main content

Table 1 Demographic and clinical characteristics of study participants (n = 331)

From: Very low rates of screening for metabolic syndrome among patients with severe mental illness in Durban, South Africa

Clinical characteristics

 

Gender n (%)

 

Male

167 (50.5%)

Female

164 (49.5%)

Ethnicity n (%)

 

African

261 (78.8%)

Indian

28 (8.5%)

White

32 (9.7%)

Coloured

10 (3%)

Age (years) mean ± SD

35.2 ± 11.98

Age distribution n (%)

 

18-30 years

141 (42.6%)

31-40 years

82 (24.8%)

41-50 years

60 (18.1%)

51-64 years

48 (14.5%)

Employment n (%)

 

Unemployed

200 (60.4%)

Formal

32 (9.7%)

Student

36 (10.9%)

Disability grant/old age pension

63 (19%)

Diagnosis n (%)

 

Schizophrenia

163 (49.3%)

Major Depressive Disorder

15 (4.5%)

Bipolar Mood Disorder

49 (14.8%)

Schizoaffective Disorder

36 (10.9%)

Mood/psychotic disorder due to a general medical condition

68 (20.5%)

Antipsychotic- medications n (%)

 

Risperidone

125(37.8%)

Chlorpromazine

37 (11.2%)

Haloperidol

54 (16.3%)

Zuclopenthixol Decanoate

19 (5.8%)

Clozapine

15 (4.5%)

Olanzapine

13 (3.9%)

Quetiapine

45 (13.6%)

Amisulpride

12 (3.6%)

Aripiprazole

11 (3.3%)

History of [n (%)]:

 

Smoking

77 (23.3%)

HIV disease

67 (20.2%)

Hypertension

12 (3.6%)

Type 2 diabetes

5 (1.5%)

  1. Results expressed as n (%) or mean ± SD.